Sessa, Maurizio http://orcid.org/0000-0003-0874-4744
Andersen, Morten
Funding for this research was provided by:
Novo Nordisk Fonden (NNF15SA0018404)
Article History
Accepted: 19 January 2021
First Online: 20 February 2021
Declarations
:
: MS and MA belong to the Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, supported by a grant from the Novo Nordisk Foundation (NNF15SA0018404).
: Morten Andersen has during the past 5 years participated in research projects supported by grants from Novartis, Pfizer, Janssen, AstraZeneca, and H. Lundbeck & Mertz, received by the universities where he has been employed. He has personally received fees from Atrium Education, the Danish Pharmaceutical Industry Association, for teaching and leading pharmacoepidemiology courses. Maurizio Sessa has no conflicts of interest to declare.
: No ethical approval is required for descriptive studies using publicly available data from FAERS.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Code is available from the corresponding author on reasonable request.
: Not applicable.
: Not applicable.